IP Library Granted Patent US 8,993,005
Granted Patent B2
US 8,993,005 · App. 12/738,510 · Granted Mar 31, 2015

Food compositions comprising lemon balm extracts

Inventors: Sybille Buchwald-Werner (Düsseldorf, DE); Claudia Scholz (Darmstadt, DE); Ralf Zink (Langenfeld, DE); Matthias Sass (Oftersheim, DE)
Assignee: Rudolf Wild GmbH & Co. KG
A23L1/3002A23C9/13A23C9/152A23L1/2225A61K36/53
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,993,005
App. No.
12/738,510
Granted
Mar 31, 2015
Kind
B2
Abstract

Disclosed are food compositions, comprising aqueous extracts of Melissa officinalis (Lemon balm) and/or its active principle rosmarinic acid. Methods of preparing a food composition, and of making a medicament, both methods comprising rosmarinic acid and/or aqueous extracts of Melissa officinalis , are also disclosed.

Claims (6)

1. A method for increasing alertness and/or improving word recognition sensitivity in a subject in need thereof, the method comprising administering to the subject a medicament comprising a water-based extract of Melissa officinalis and a pharmaceutical base, wherein the water-based extract of Melissa officinalis is present in an amount in the range of about 0.1 to about 50 g/L.

2. The method of claim 1 , wherein the water-based extract of lemon balm is present in an amount in the range of about 2 to about 25 g/L.

3. The method of claim 1 , further comprising adding physiologically active fatty acids and/or sterols or sterol esters to the pharmaceutical base.

4. The method of claim 1 , wherein the water-based extract of Melissa officinalis is micro-encapsulated.

5. The method of claim 1 , wherein the pharmaceutical base is a liquid comprising about 1.8 grams/200 mL of the aqueous extract of Melissa officinalis.

6. The method of claim 1 , wherein the patient exhibits increased alertness and/or improved word recognition sensitivity up to about 6 hours after treatment.

Assignments (3)
CHANGE OF NAME Recorded Sep 21, 2017
From: RUDOLF WILD GMBH & CO. KG
To: ADM WILD EUROPE GMBH & CO. KG
Reel/Frame 043936/0858 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2012
From: COGNIS IP MANAGEMENT GMBH
To: RUDOLF WILD GMBH & CO. KG
Reel/Frame 029518/0510 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2010
From: BUCHWALD-WERNER, SYBILL; SCHOLZ, CLAUDIA; ZINK, RALF; SASS, MATTHIAS
To: COGNIS IP MANAGEMENT GMBH (COGNIS)
Reel/Frame 025005/0728 →
Priority Claims (1)
EP 07020260 · Oct 17, 2007 · regional
Continuity (1)
Related Publication 20100297266A1 · Nov 25, 2010